Biocon, Mylan win patent rights for Insulin Glargine Device against Sanofi Medical Dialogues Bureau12 March 2020 11:29 AM ISTInsulin Glargine is a long-acting insulin used to treat adults with Type 2 diabetes and adults and paediatric patients with Type 1 diabetes for the...
Biocon appoints Christiane Hamacher as CEO of Biocon Biologics India Farhat Nasim2 March 2019 11:00 AM IST"Christiane joins us at a critical inflexion point in the business as we build our stature in the large and growing opportunity for biosimilar...